Strata Critical Medical (SRTA) Earnings Analysis

Strata Critical Medical (SRTA) has no confirmed upcoming earnings date. Last quarter (2026-03-03) it missed with EPS -0.06214 USD vs 0.01 USD est (-721.4%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -31.11.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SRTA next report earnings?

No confirmed upcoming earnings date is currently scheduled for SRTA. This page updates as the calendar is published.

SRTA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-03-0.06214 USD0.01 USD-721.4%Miss
2025-11-10-0.06 USD-0.02 USD-200%Miss
2025-05-12-0.04 USD-0.11 USD+63.6%Beat
2025-03-13-0.12 USD-0.12 USD0%Beat

Beat rate: 2/4 (50%) over reported quarters with consensus data.

SRTA valuation and analyst view

Trailing P/E-31.11
Trailing EPS0.55078 USD
Price / book1.52
Dividend yield0.00%
Market cap0.44B
Analyst consensusBuy (6 buy / 0 hold / 0 sell)
Avg price target7.25 USD

Related research pages

Frequently asked questions

When is Strata Critical Medical (SRTA)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for SRTA. This page updates as the calendar is published.

Did SRTA beat earnings last quarter?

In its 2026-03-03 report, SRTA posted EPS of -0.06214 USD versus a 0.01 USD estimate — a miss of 721.4%.

What is SRTA's earnings track record?

Over the last 4 reported quarters with consensus data, SRTA beat estimates 2 times (50%).

What is SRTA's current P/E ratio and EPS?

SRTA trades at a trailing P/E of -31.11 on trailing EPS of 0.5507780140865046 USD.

What do analysts rate SRTA?

Analyst consensus is "Buy" across 6 ratings (0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 7.25 USD.